Expecting FDA approval of Ketamine in Q2-2025 Solving the shortage problem of Ketamine and unlocking its pharmaceutical potential Toronto, Ontario–(Newsfile Corp. – March 3, 2025) – PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the “Company” or “PharmaTher”), a specialty pharmaceutical company, is pleased to announce today that the Company has provided its resubmission to the […]